Pennsylvania schools close after first pediatric coronavirus case identified

By Christen Smith |

The Center Square

(The Center Square) – Pennsylvania Gov. Tom Wolf closed all public schools Friday, just hours after health officials confirmed the state\’s first case of novel coronavirus diagnosed in a patient younger than 18.

The shutdown will last 10 business days through March 30, at which time Wolf said the state will reevaluate the situation.

“We understand that these are trying times and recognize the impact of the coronavirus on our students and communities,” he said. “First and foremost, my top priority as governor – and that of our education leaders – must be to ensure the health and safety of our students and school communities.”

Secretary of Health Dr. Rachel Levine said this is the first known pediatric case in the state, where so far 33 residents have tested positive for COVID-19. Of the 300 tested, 140 have come back negative and 130 more are pending, Levine said.

No other details were released about the pediatric patient, except that the case was from Monroe County. Thursday, the governor recommended statewide social distancing policies and shut down schools and public buildings in Montgomery County, the epicenter of the coronavirus outbreak. He expanded that mandate to all schools across Pennsylvania’s 67 counties Friday afternoon.

Schools will not be penalized for falling short of the 180-day instruction requirement, Wolf said. The Department of Education will provide breakfast and lunch to low-income students during the two-week closure.

The federal Centers for Disease Control and Prevention said children don’t appear as susceptible to the more severe symptoms of COVID-19, though it is unknown why.

So far, the CDC has confirmed 1,629 cases across 46 states and Washington D.C., with 41 reported deaths. Worldwide, more than 133,000 people have contracted the virus and nearly 5,000 have died.

published here by The Gloucestercitynews.net with permission of

The Center Square

Guest Opinion: Let\’s Not Panic

Well, I\’d have to say that 2020 is off to a hell of a start.  From giant fires ravaging the country of Australia, the death of NBA icon Kobe Bryant, the Coronavirus, stock market volatility and of all things, Prince Harry wants out of the royal family!

Here\’s what I know; I\’m grateful for today and I\’ll take it as it comes.  I\’m not

going to play into the fear-mongering on social media when it comes to stock market declines or Coronavirus.  My solution is pretty simple; diversify, buy real estate for cash flow, wash my hands frequently and keep trucking along.

On Facebook this week I saw a lot of stoking the fire of fear when it comes to stocks vs. real estate. I don\’t agree with that tactic as I continue to own both stocks along with my real estate.  Maybe it\’s the former financial advisor in me, but I don\’t get too emotional when it comes to investments.  I make decisions based upon data and return on investment and believe me when I say, that this wasn\’t learned overnight.  I got absolutely destroyed in the recession and learned some painful lessons about emotions and following the crowd.

This week I posted on Facebook about a partial note with a 12% yield that we were looking to sell and I had multiple IRA holders in my network reach out to purchase it.  If you don\’t know what a partial note is, you can learn more about that

HERE

on our YouTube Channel, but in a nutshell it means that I\’m selling a portion of the payments on a note that I own for a period of time.  These are ideal for IRA holders that may want to hold some cash flowing assets in their portfolio along with their stocks and bonds.  Did you know that you can also hold these assets in an account for your kids, HSA, Roth or even 401k?

I don\’t think you should have all of your eggs in one basket which is why I own different businesses, stocks, bonds, notes and of course real estate.  If you are interested in adding some notes to your portfolio as an income producer, reach out and let\’s schedule a call to learn more about your investment goals to see if they\’re a fit.

It\’s a crazy world we live in and that will continue on.  I\’m grateful to have you in my network and I hope you stay healthy and happy!

PS:  Don\’t forget to wash your hands!  😉

Regards,

Ben Fredricks

Odell Barnes REO

www.OdellBarnesREO.com

You Could Be Part Of The 33 Percent

One in three American adults are at risk of life-threatening kidney disease, and most don’t know it—but that can be remedied.

(NAPSI)—Look around the next time you’re in a crowd. One-third of everyone in there with you is at risk of developing dangerous kidney disease.

Kidney Disease Facts

In the United States, 37 million adults are estimated to have chronic kidney disease—and more than 90% aren’t aware of it. Often there are no symptoms; they won’t find out until their kidney’s fail. Kidneys are vital organs—as important as your heart, liver or lungs—that work 24/7 to clean toxins from your body. No one can live without functioning kidneys. When kidneys fail, only immediate dialysis or a transplant can save you.

A Solution

The National Kidney Foundation (NKF)—the largest, most comprehensive, and longstanding patient-centric organization dedicated to the awareness, prevention, and treatment of kidney disease in the U.S.—wants to change the odds. Every adult in the United States needs to know the risk and can find out with a simple, one-minute online quiz rolled out for National Kidney Month in March that can let you know if you’re in the 33 percent—and what to do about it.

“We have a public health crisis that needs to be addressed by all Americans,” said NKF CEO and kidney transplant recipient Kevin Longino. “We will never give up trying to find ways to reach people, slow or stop the progression of this disease and lessen the burden for patients. Early testing and interventions are the key.”

What To Watch For

Risk factors for kidney disease are:

•    High blood pressure

•    Heart disease

•    Diabetes

•    Obesity

•    A family history of kidney disease.

What To Do

If you have one or more of these factors, you should to go to

MinuteForYourKidneys.org

to find out what to do next and how to talk to your doctor about it.

Life-threatening kidney disease can strike anyone, young or old, and has many causes, but early intervention can make a difference. Lifestyle changes and a healthy diet can sometimes slow the progression of the disease when caught in the early stages, and sometimes can stop kidney failure.

The first step to preventing kidney failure is knowing your risk, then getting tested. Two simple tests, one blood and one urine, can let your doctor know how your kidneys are doing. It’s easy to get tested yet the results can save your life.

Learn More

For further information about NKF, visit

www.kidney.org

.

RELATED:

THAT\’S LIFE, by WE Cleary Sr.

Gloucester City Staying on Top of the Corona Virus Crisis

GLOUCESTER CITY, NJ (March 11, 2020)–Gloucester City Mayor Daniel Spencer has released the following statement regarding the City\’s response to the Corona Virus crisis.

City of Gloucester officials have been in constant contact with representatives of the Camden County Health Department and Office of Emergency Management on the ever-widening Corona Virus crisis.

The City and its various departments have been meeting on this issue and are doing everything in their power to help educate the citizens of Gloucester City and to do their part in containing this virus.

There are several simple steps to protect yourself regarding the Corona Virus

Clean your hands often with soap and water

Avoid close contact

Stay home if your sick

Cover coughs and sneezes

Wear a face mask if you are sick

Clean and Disinfect at least twice a day for high traffic areas such as phones, doorknobs, light switches

Seek Medical advice if symptomatic

Additional information can be viewed on the State of New Jersey website at state.nj.us and the Centers for Disease Control website at cdc.gov

RELATED:

Murphy Declares State of Emergency, Public Health Emergency

Dr. Oz Coronavirus Survival Guide

FIRST RESPONDERS! Coronavirus Summit

GTPD Alert: Coronavirus Preparedness

Knowledge is power: Get facts straight during Colorectal Awareness Month

Did you know that colorectal cancer (CRC) is the third leading cause of cancer death among American men and women combined? One out of every three people are not up-to-date with screenings.

Sadly, 60 percent of colorectal cancer deaths could be prevented with screening: in fact, getting screened routinely starting at age 45 or 50, at the latest — is the most effective way to reduce your risk.

Abnormal growths, called polyps, can form in the colon or rectum. Through screenings, they can be removed early, before becoming cancerous.  A person’s CRC risk increases as they age; about 90 percent of cases occur in adults 50 and up.

Some risk factors include:

Inflammatory bowel disease, such as Crohn’s disease or ulcerative colitis

A personal or family history of colorectal cancer or colorectal polyps

A genetic syndrome, such as familial adenomatous polyposis (FAP) or hereditary non-polyposis colorectal cancer (Lynch syndrome).

The U.S. Multi-Society Task Force of Colorectal Cancer recommends:

People at average risk of CRC start regular screenings at 50.

African Americans at average risk of CRC start regular screenings at 45.

People in good health, and with a life expectancy of more than 10 years, continue regular CRC screenings through the age of 75.

People ages 76 through 85 should make a decision regarding screenings with their medical provider, based on personal preferences, life expectancy, overall health, and prior screening history.

People over 85 should no longer get CRC screening.

Decrease your risk for colorectal cancer with these lifestyle changes:

Regular physical activity

A diet high in fruits and vegetables

A high-fiber, low-fat diet or one that eliminates processed meats (cold cuts, sausage, bacon)

Eating less red meat

Limiting alcohol consumption

Avoiding tobacco use.

The recommended tests fall into two categories:

Stool-based tests are non-invasive and require no special diet or bowel preparation. If the test shows abnormal signs of blood, or a possible cancer or pre-cancer, a colonoscopy will be needed to confirm the result, and possibly remove any abnormal findings or polyps.

Visual or Structural tests are invasive tests that look inside the colon and rectum for abnormal areas that might be cancer or polyps. If a stool-based test was done first and had an abnormal result, a visual test, such as colonoscopy, can help find out why.

To prepare, you are asked to follow a special diet in advance and will also need to clean out your colon with strong laxatives (called a bowel prep) and sometimes with enemas, as well. Most people are sedated during the test.

Talk to your care provider about which screening option is the best for you. The life you save could be your own!

Jefferson Health Foundation – New Jersey 2020 Gala Raises Nearly $900K for Planned Jefferson Pride Primary and Specialty Care Practice

Nearly

900 supporters of Jefferson Health New Jersey enjoyed an evening of dancing and dining at the organization’s 24

th

annual Jefferson Health Foundation – New Jersey fundraising Gala, held at Borgata Hotel Casino & Spa in Atlantic City. The February 29

th

event — headlined by performances from Motown legends The Temptations and Four Tops — raised close to $900,000 to benefit the planned Jefferson Pride Primary & Specialty Care practice, set to open in Collingswood later this year. For more information, visit

JeffersonHealth.org/JeffPrideNJ

.

Shown, from left

: Colleen Wyse and husband, Dr. Stephen K. Klasko, President, Thomas Jefferson University, and CEO of Jefferson Health; and Dina Devine and husband, Joseph W. Devine, President of Jefferson Health New Jersey, and Chief Experience Officer, Jefferson Health.

Temple’s Dr. Silvia Fossati Awarded $500,000 Grant for Alzheimer’s Disease Drug Discovery Research

(Philadelphia, PA) – Silvia Fossati, PhD,

Associate Professor of Pharmacology and Associate Director of the Alzheimer’s Center at Temple at the Lewis Katz School of Medicine, has been awarded a two-year $500,000 grant from The Edward N. and Della L. Thome Memorial Foundation, Bank of America, N.A., Trustee, as part of the Foundation’s Awards Program in Alzheimer’s Disease Drug Discovery Research.

Dr. Fossati, the principal investigator on the grant, will work with co-investigator

Marc Ilies, PhD,

Professor in the Department of Pharmaceutical Sciences at the Temple University School of Pharmacy, to develop a new Alzheimer’s-specific version of an already-existing drug family called carbonic anhydrase inhibitors, which are approved by the U.S. Food and Drug Administration (FDA) to treat conditions such as glaucoma and high-altitude sickness.

Previous studies in Dr. Fossati’s Lab showed that these drugs were effective in cell and animal models at targeting certain features of Alzheimer’s disease, including mitochondrial dysfunction, amyloid protein build-up, and inflammation.

Research has suggested that chronic inflammation in the brain may be due to the build-up of cells that normally free the organ of debris, waste and protein collections – including amyloid protein. When amyloid protein deposits in abnormal levels in the brain, it can disrupt cell function and communication pathways. Elevated levels can also be a factor in abnormalities of the mitochondria – the energy-generating batteries of cells – and in damaging the brain vasculature (its blood vessels). Collectively, these can eventually contribute to cognitive dysfunction, including impairments in memory and learning – hallmarks of Alzheimer’s disease.

Ideally, Dr. Fossati and Dr. Ilies’ drug would target these characteristics, as currently available carbonic anhydrase inhibitors do, but would better infiltrate the brain and cause fewer side effects.

The drug would be tested in cell and animal models of Alzheimer’s disease first and then potentially in human clinical trials in two to three years.

“Since carbonic anhydrase inhibitors have already been approved by the FDA and have demonstrated promising results, we are hopeful that we will be able to tailor what is currently available on the market to specifically target Alzheimer’s disease,” Dr. Fossati said. “We are so thankful that the foundation sees such promise in our work and has chosen to recognize us with this grant.”

The Edward N. and Della L. Thome Memorial Foundation, Bank of America, N.A., Trustee, which was established in 2002 by Robert P. Thome to honor the memory of his parents, provides funding in two areas – support for the dignified treatment of older adults and support for medical research on diseases affecting older adults. The medical research division alternates between funding research on macular degeneration and Alzheimer’s disease.

About Temple Health

Temple University Health System (TUHS) is a $2.2 billion academic health system dedicated to providing access to quality patient care and supporting excellence in medical education and research. The Health System consists of Temple University Hospital (TUH)

;

TUH-Episcopal Campus; TUH-Jeanes Campus; TUH-Northeastern Campus; The Hospital of Fox Chase Cancer Center and Affiliates, an NCI-designated comprehensive cancer center; Temple Transport Team, a ground and air-ambulance company; Temple Physicians, Inc., a network of community-based specialty and primary-care physician practices; and Temple Faculty Practice Plan, Inc., TUHS’s physician practice plan comprised of more than 500 full-time and part-time academic physicians in 20 clinical departments. TUHS is affiliated with the Lewis Katz School of Medicine at Temple University.

Temple Health refers to the health, education and research activities carried out by the affiliates of Temple University Health System (TUHS) and by the Katz School of Medicine. TUHS neither provides nor controls the provision of health care. All health care is provided by its member organizations or independent health care providers affiliated with TUHS member organizations. Each TUHS member organization is owned and operated pursuant to its governing documents.

It is the policy of Temple University Health System that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

Camden Girl Scouts Visit MD Anderson Cancer Center

Through a partnership with The Cooper Foundation, the Girl Scouts of Central & Southern New Jersey, St. Joseph’s Pro-Cathedral School and KIPP Cooper Norcross Academy, 24 Camden middle school students visited MD Anderson Cancer Center at Cooper on Jan. 30 for a behind the scenes look at STEM (Science, Technology, Engineering and Math) careers.

During the tour of the state-of-the-art cancer center, students had the opportunity to hear from a radiation therapist, an infusion nurse, a pharmacist, and a clinical researcher to learn about their work and the technology used to care for patients.

Following the tour, Dr. Lisa Reid, a surgeon at MD Anderson at Cooper, shared the story of her career path and encouraged the girls to find their voice and follow their dreams.

Last year, Camden high school students visited Cooper as part of the STEMsational: STEM Girl Scouts Series. This year, the opportunity was extended to middle school students to encourage them to discover their passions and hear from women in leadership roles.

Click here

to view photos from the tour.

A Little Girl from Indiana is Pursuing Her Dreams Thanks to Her New Kidney

March is National Kidney Month:

March 2, 2020

March is National Kidney Month, which is a month-long, awareness-raising grassroots effort to spread the word nationwide about the importance of kidney health. An Indiana transplant family knows all too well the life-saving difference a

healthy kidney can make.

Paula and David Check of Fishers, Indiana, remember the excitement of learning they were pregnant with their first child. Paula’s pregnancy was normal by all accounts and they were simply counting the days until their precious baby would be born. Baby Lydia arrived in December 2009 and the family of three felt complete. She was an adorable infant who grew into a toddler — her first years of life seemed ‘normal’ to both Paula and David.

But during the summer months of 2014 Paula noticed then four-year-old Lydia was becoming increasingly sick, tired and weak. By the fall months Lydia was vomiting and having diarrhea regularly. She began bleeding from her bowels. Paula remembers taking Lydia to the family doctor several times insisting there was something seriously wrong with their little girl. In January 2015 Lydia’s weight loss became incredibly noticeable; she was literally skin and bones. In February 2015 a gastro intestinal specialist diagnosed Lydia with Ulcerative Colitis, which meant she had bleeding ulcers in her stomach and colon. Eight months later in September 2015 it was determined Lydia also had a serious kidney issue that would require a kidney transplant for her long-term survival.

Lydia, with a little help from her mom, has written a narrative about her transplant journey. Here is how Lydia tells her transplant story to date:

Hello my name is Lydia, I am 10 years old, and the last six years have been really difficult. I have been sick since August 2014 with an autoimmune disorder. When I was younger I was weak, tired and had extreme weight loss. My parents took me to the doctor repeatedly, always telling him something was wrong. But my problem went undiagnosed until January 2015. That is when I began treatment for Ulcerative Colitis. After several doctor appointments and medications, it went into remission.

In August 2015 something was not right with my kidney function. Labor Day weekend I was admitted to Riley Hospital for Children and I had a biopsy performed. I spent the entire day in bed. I was required to lay flat on my back to prevent bleeding from the procedure. The next three days in the hospital I was given super strength IV steroids. I initially showed improvement from the steroids and was sent home on Labor Day afternoon. Steroids work great for some people but I was not showing signs of improvement — just the side effects of weight gain, a puffy face, lots of emotions and not being able to sleep through the night. In May 2016 a G Tube was placed in my belly so medications could go right to my tummy. An overnight drip of Pedialyte was started to keep me from dehydrating. Testing determined I have a genetic disease.

Lydia’s diagnosis, Nephronophthisis, is a

genetic disorder

of the

kidneys

that affects children. The disorder is inherited in an

autosomal recessive

fashion and, although rare, is the most common genetic cause of childhood kidney failure. Although the range of characterizations is broad, those kids affected by nephronophthisis typically produce a large volume of urine, drink excessive amounts of liquid, and after several months to years, develop

end stage renal (kidney) disease

— a condition necessitating either dialysis or a kidney transplant in order to survive.

As Lydia’s kidney disease progressed, Paula and David started meeting with the transplant team at Riley Hospital for Children. In January 2017, upon a transplant social worker’s urging, Paula called the Children’s Organ Transplant Association (COTA) to learn more about fundraising for transplant-related expenses. COTA is a 501(c)3 charity so all contributions to COTA in honor of Lydia are tax deductible to the fullest extent of the law, and COTA funds are available for a lifetime of transplant-related expenses. COTA uniquely understands that parents who care for a child or young adult before, during and after a life-saving transplant have enough to deal with, so COTA’s model shifts the responsibility for fundraising to a community team of trained volunteers. On February 24th Lydia became part of the COTA Family.

A COTA fundraising specialist travelled to Fishers, Indiana, on March 20th to train the family’s volunteers and walked them through the entire process. This group of family members and friends quickly got to work organizing fundraisers to help with mounting transplant-related expenses. According to Paula, COTA’s team of professionals was supportive, encouraging and very helpful every step of the journey.

Once we found out I needed a new kidney, several people started the testing process to see if they could be my living donor. Those tests were unsuccessful. In late 2017 I was approved to be on the national kidney waiting list. However my wait was long and in August 2018 I went from low kidney function to kidney failure.

That is when the doctors told us it was time to begin dialysis. Our family decided hemodialysis was the best choice and I went in for the surgery that would allow me to be on dialysis. During the first surgery I lost a lot of blood and needed a blood transfusion. Then they were unable to get the dialysis machine up to full speed during my first treatment. It was decided there was a problem with my central line and they needed to do surgery again. This time it worked. I was on dialysis four hours a day, three days a week. It was long and exhausting.

On August 31, 2018, right when we got home from dialysis, Mom got a phone call from Riley. They had a kidney match for me! It was an emotional roller coaster. I was happy. I was scared. I had no idea what to expect. The next day on September 1

st

, I received my new kidney and the transplant was a big success. Sixteen days later on September 17

th

I was released from the hospital to go home. Wow.

“I knew Lydia’s transplant surgery and follow-up care and medications and everything would be very expensive. Once we found COTA a huge stressor was lifted from our shoulders. If we had not been introduced to COTA our family would have been very lost during a time of tremendous need. COTA gave us the strength and direction we needed to get through a very challenging chapter in our family’s story,” Paula said.

“The Children’s Organ Transplant Association (COTA) gave us hope when we were feeling hopeless. COTA’s team of professionals were supportive and encouraging every step of the way. Knowing COTA funds are not just for the expenses leading up to a transplant but will be there throughout Lydia’s life is truly amazing. If we had not found COTA, we would have been lost during a time of tremendous need. COTA gives our family strength and direction, and will continue to do so …

for a lifetime

,” Paula said.

Lydia returned to Fall Creek Elementary and completed third grade with her new kidney. She also was able to return to her beloved dance classes at Wishes Dance Studio. When asked how life has been with her new kidney Lydia said, “I have done amazing things like riding on my very own float in the Fishers Spark Parade, running in a Super Hero 5K, going to my first Indiana Pacers game, and meeting Mickey & Minnie Mouse.” These days dancing remains at the top of the list of the things Lydia enjoys doing, but she also loves singing, pretending she is a Super Hero, cheerleading and meeting Disney princesses. She also loves to tell the story of her transplant journey.

Lydia’s new lease on life has allowed her to start dreaming about a future, which is the best gift Paula and David can imagine for their vivacious girl who has a huge smile and a huge heart. Lydia’s bucket list currently includes taking a Disney Cruise, seeing the Eiffel Tower in Paris, meeting Taylor Swift and having tea with the Queen of England.

In Lydia’s word, “Wow.”

March is designated National Kidney Month to raise awareness about the prevention and early detection of kidney disease. More than 30 million Americans have kidney disease, and many do not know it. There are more than 100,000 people waiting for kidney transplants, with close to 600,000 people in the United States suffering with kidney failure. More than 3,000 new patients are added to the kidney waiting list each month; 13 people die each day while waiting for a life-saving kidney transplant. Every 14 minutes someone is added to the kidney transplant list. You can visit

www.RegisterMe.org

to indicate your wish to be a life-saving donor.

For more information about the Children’s Organ Transplant Association (COTA),

or to find a COTA family in your area, please email

kim@cota.org

.

COVID-19 a Reminder of the Challenge of Emerging Infectious Diseases

This transmission electron microscope image shows SARS-CoV-2—also known as 2019-nCoV, the virus that causes COVID-19—isolated from a patient in the U.S. Virus particles are shown emerging from the surface of cells cultured in the lab. The spikes on the outer edge of the virus particles give coronaviruses their name, crown-like.

NIAID-RML

What

The emergence and rapid increase in cases of coronavirus disease 2019 (COVID-19), a respiratory illness caused by a novel coronavirus, pose complex challenges to the global public health, research and medical communities, write federal scientists from NIH’s National Institute of Allergy and Infectious Diseases (NIAID) and from the Centers for Disease Control and Prevention (CDC). Their commentary appears in

The New England Journal of Medicine.

NIAID Director Anthony S. Fauci, M.D., NIAID Deputy Director for Clinical Research and Special Projects H. Clifford Lane, M.D., and CDC Director Robert R. Redfield, M.D., shared their observations in the context of a recently published

report

on the early transmission dynamics of COVID-19. The report provided detailed clinical and epidemiological information about the first 425 cases to arise in Wuhan, Hubei Province, China.

In response to the outbreak, the United States and other countries instituted temporary travel restrictions, which may have slowed the spread of COVID-19 somewhat, the authors note. However, given the apparent efficiency of virus transmission, everyone should be prepared for COVID-19 to gain a foothold throughout the world, including in the United States, they add. If the disease begins to spread in U.S. communities, containment may no longer be a realistic goal and response efforts likely will need to transition to various mitigation strategies, which could include isolating ill people at home, closing schools and encouraging telework, the officials write.

Drs. Fauci, Lane and Redfield point to the many research efforts now underway to address COVID-19. These include numerous vaccine candidates proceeding toward early-stage clinical trials as well as clinical trials already underway to test candidate therapeutics, including an

NIAID-sponsored trial of the experimental

antiviral drug remdesivir that began enrolling participants on February 21, 2020.

“The COVID-19 outbreak is a stark reminder of the ongoing challenge of emerging and re-emerging infectious pathogens and the need for constant surveillance, prompt diagnosis and robust research to understand the basic biology of new organisms and our susceptibilities to them, as well as to develop effective countermeasures,” the authors conclude.

Article

AS Fauci

et al.

COVID-19: Navigating the uncharted.

The New England Journal of Medicine.

DOI: 10.1056/NEJMp2002387 (2020).

Q Li

et al.

Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia

.

The New England Journal of Medicine.

DOI: 10.1056/NEJMoa2001316 (2020).